ASX - By Stock
|
AVE |
Re:
Avecho channel 7
|
|
gavval
|
41 |
9.8K |
0 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
41
|
9.8K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
gavval
|
71 |
21K |
0 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
71
|
21K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Global Cannabidiol (CBD) Market Size to Grow at a CAGR of 51% from 2021 to 2030
|
|
gavval
|
33 |
9.4K |
1 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
33
|
9.4K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Global Cannabidiol (CBD) Market Size to Grow at a CAGR of 51% from 2021 to 2030
|
|
gavval
|
33 |
9.4K |
2 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
33
|
9.4K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE receives firm commitment to raise $5.06 via placement
|
|
gavval
|
37 |
9.7K |
5 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
37
|
9.7K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Grant of Unlisted Options & Appendix 3G
|
|
gavval
|
28 |
7.2K |
2 |
29/11/20 |
29/11/20 |
ASX - By Stock
|
28
|
7.2K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Grant of Unlisted Options & Appendix 3G
|
|
gavval
|
28 |
7.2K |
2 |
29/11/20 |
29/11/20 |
ASX - By Stock
|
28
|
7.2K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Grant of Unlisted Options & Appendix 3G
|
|
gavval
|
28 |
7.2K |
3 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
28
|
7.2K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Grant of Unlisted Options & Appendix 3G
|
|
gavval
|
28 |
7.2K |
2 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
28
|
7.2K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
The Countdown ...
|
|
gavval
|
221 |
50K |
1 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
221
|
50K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
The Countdown ...
|
|
gavval
|
221 |
50K |
2 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
221
|
50K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: 2020 Annual General Meeting Results
|
|
gavval
|
2 |
972 |
2 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
2
|
972
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
gavval
|
16 |
3.7K |
0 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
16
|
3.7K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Medicinal cannabis supply agreement with Tasmanian Alkaloids
|
|
gavval
|
69 |
18K |
3 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
69
|
18K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Chairman's Address
|
|
gavval
|
35 |
10K |
2 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
35
|
10K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Chairman's Address
|
|
gavval
|
35 |
10K |
8 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
35
|
10K
|
8
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Injectable Portfolio Update - Products Differentiated by TPM
|
|
gavval
|
136 |
66K |
1 |
04/12/19 |
04/12/19 |
ASX - By Stock
|
136
|
66K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
FDA on new opioids
|
|
gavval
|
26 |
9.5K |
2 |
11/09/19 |
11/09/19 |
ASX - By Stock
|
26
|
9.5K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
FDA on new opioids
|
|
gavval
|
26 |
9.5K |
0 |
10/09/19 |
10/09/19 |
ASX - By Stock
|
26
|
9.5K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
TPM Injectables
|
|
gavval
|
53 |
19K |
3 |
10/08/19 |
10/08/19 |
ASX - By Stock
|
53
|
19K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Ashland purchases manufacturing rights for Vital ET and TPM
|
|
gavval
|
25 |
9.9K |
0 |
21/06/19 |
21/06/19 |
ASX - By Stock
|
25
|
9.9K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Annual Report - 31 December 2018
|
|
gavval
|
17 |
8.6K |
1 |
27/03/19 |
27/03/19 |
ASX - By Stock
|
17
|
8.6K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Updated Presentation to Support CEO Partnering Meetings
|
|
gavval
|
49 |
19K |
0 |
27/02/19 |
27/02/19 |
ASX - By Stock
|
49
|
19K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: FDA meeting provides guidance for TPM/Oxymorphone patch
|
|
gavval
|
58 |
23K |
3 |
25/01/19 |
25/01/19 |
ASX - By Stock
|
58
|
23K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Resignation and Appointment of Company Secretary and CFO
|
|
gavval
|
25 |
10K |
3 |
24/12/18 |
24/12/18 |
ASX - By Stock
|
25
|
10K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Receipt of R&D Tax Incentive
|
|
gavval
|
26 |
9.4K |
0 |
30/11/18 |
30/11/18 |
ASX - By Stock
|
26
|
9.4K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Arbitration Award Issued
|
|
gavval
|
260 |
110K |
0 |
21/11/18 |
21/11/18 |
ASX - By Stock
|
260
|
110K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Arbitration Award Issued
|
|
gavval
|
260 |
110K |
4 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
260
|
110K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Arbitration Award Issued
|
|
gavval
|
260 |
110K |
4 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
260
|
110K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Receives Further Arbitration Process Update
|
|
gavval
|
164 |
43K |
2 |
24/10/18 |
24/10/18 |
ASX - By Stock
|
164
|
43K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Receives Further Arbitration Process Update
|
|
gavval
|
164 |
43K |
6 |
23/10/18 |
23/10/18 |
ASX - By Stock
|
164
|
43K
|
6
|
|
ASX - By Stock
|
AVE |
Re:
Terumo expands injectables capacity
|
|
gavval
|
9 |
4.7K |
3 |
13/07/18 |
13/07/18 |
ASX - By Stock
|
9
|
4.7K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Terumo expands injectables capacity
|
|
gavval
|
9 |
4.7K |
4 |
13/07/18 |
13/07/18 |
ASX - By Stock
|
9
|
4.7K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
RE: Mylan Arbitration
|
|
gavval
|
9 |
2.8K |
1 |
22/05/18 |
22/05/18 |
ASX - By Stock
|
9
|
2.8K
|
1
|
|
ASX - By Stock
|
AVE |
RE: Mylan Arbitration
|
|
gavval
|
9 |
2.8K |
0 |
22/05/18 |
22/05/18 |
ASX - By Stock
|
9
|
2.8K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
And.......if we win!
|
|
gavval
|
47 |
13K |
1 |
19/05/18 |
19/05/18 |
ASX - By Stock
|
47
|
13K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
And.......if we win!
|
|
gavval
|
47 |
13K |
0 |
18/05/18 |
18/05/18 |
ASX - By Stock
|
47
|
13K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
And.......if we win!
|
|
gavval
|
47 |
13K |
1 |
18/05/18 |
18/05/18 |
ASX - By Stock
|
47
|
13K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
And.......if we win!
|
|
gavval
|
47 |
13K |
1 |
18/05/18 |
18/05/18 |
ASX - By Stock
|
47
|
13K
|
1
|
|
ASX - By Stock
|
AVE |
And.......if we win!
|
|
gavval
|
47 |
13K |
0 |
18/05/18 |
18/05/18 |
ASX - By Stock
|
47
|
13K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Preliminary Final Report
|
|
gavval
|
61 |
19K |
0 |
28/02/18 |
28/02/18 |
ASX - By Stock
|
61
|
19K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
New technology
|
|
gavval
|
33 |
9.6K |
0 |
27/02/18 |
27/02/18 |
ASX - By Stock
|
33
|
9.6K
|
0
|
|